Skip to main content
. 2020 May 8;12(6):910–933. doi: 10.4168/aair.2020.12.6.910

Fig. 1. Approach to uncontrolled, difficult-to-treat, and severe asthma.

Fig. 1

ANCA, anti-neutrophil cytoplasmic antibodies; FEV1, forced expiratory volume in 1 second; GINA, Global Initiative for Asthma; ICS, inhaled corticosteroids; CRS, chronic rhinosinusitis; GERD, gastroesophageal reflux disease; OSA, obstructive sleep apnea; FeNO, fractional exhaled nitric oxide; CT, computed tomography; IgE, immunoglobulin E.